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In the budding yeast Saccharomyces cerevisiae, the
multifunctional protein Net1 is implicated in regulating
the cell cycle function of the Cdc14 protein phosphatase.
Genetic and cell biological data suggest that during in-
terphase and early mitosis Net1 holds Cdc14 within the
nucleolus where its activity is suppressed. Upon its tran-
sient release from Net1 at late anaphase, active Cdc14
promotes exit from mitosis by dephosphorylating tar-
gets in the nucleus and cytoplasm. In this paper we
present evidence supporting the proposed role of Net1
in regulating Cdc14 and exit from mitosis. We show that
the NH2-terminal fragment Net1(1–600) directly binds
Cdc14 in vitro and is a highly specific competitive inhib-
itor of its activity (Ki 5 3 nM) with five different sub-
strates including the physiologic targets Swi5 and Sic1.
An analysis of truncation mutants indicates that the
Cdc14 binding site is located within a segment of Net1
containing residues 1–341. We propose that Net1 inhibits
by occluding the active site of Cdc14 because it acts as a
competitive inhibitor, binds to a site located within the
catalytic domain (residues 1–374), binds with reduced
affinity to a Cdc14 C283S mutant in which an active site
Cys is replaced, and is displaced by tungstate, a transi-
tion state analog known to bind in the catalytic site of
protein-tyrosine phosphatases.
The Cdc14 phosphatases are a conserved subset of dual
specificity enzymes (1–3) of the protein-tyrosine phosphatase
(PTP)1 family (4–7). The essential Cdc14 phosphatase from
budding yeast (1, 8–10), Saccharomyces cerevisiae, is involved
in driving cells from late anaphase into G1 of the subsequent
cell cycle, a series of events known as exit from mitosis (for
review, see Refs. 11–13). The onset of mitosis occurs when
cyclin-dependent kinases are activated following their associa-
tion with mitotic cyclins. Exit from mitosis requires the inac-
tivation of cyclin-dependent kinases, a process that involves
the ubiquitination and subsequent destruction of cyclins and
other regulatory proteins. The anaphase-promoting complex/
cyclosome (APC/C) is a tightly regulated multisubunit ubiq-
uitin ligase that first initiates anaphase, then exit from mito-
sis, by targeting proteins for degradation in an ordered and
tightly coordinated fashion (for review, see Ref. 14). In budding
yeast, inactivation of the mitotic cyclin-dependent kinase
(Cdc28) occurs by two processes, the APC/C-dependent ubiq-
uitination and subsequent destruction of B-type cyclins
(Clb1–6) and the synthesis of the Clb/Cdc28 inhibitor Sic1 (12,
13). Cdc14 drives both of these processes by dephosphorylating
at least three targets: Hct1, Swi5, and Sic1 (8, 10). Cdc14
dephosphorylates inhibitory sites and thereby activates the
APC/C regulator Cdh1/Hct1 so that a subset of mitotic cyclins,
Clb2 and Clb3, is targeted for ubiquitination by the APC/C (8,
10). Swi5 is a zinc finger transcription factor that is required
for expression of the SIC1 gene. The dephosphorylation of Swi5
permits its translocation from the cytoplasm to the nucleus
where it can activate Sic1 transcription (8). The Sic1 protein
itself may be protected from premature degradation when de-
phosphorylated by Cdc14 (8).
Net1 (also known as Cfi1) is a core component of the nucle-
olar RENT complex that regulates Cdc14 during the cell cycle
(for review, see Refs. 15–17). From G1 to anaphase, Net1 se-
questers Cdc14 in the nucleolus, where its access to substrate
is limited, and its phosphatase activity is suppressed (18–20).
At late anaphase, Cdc14 is transiently released from Net1
permitting the active phosphatase to reach targets in the nu-
cleus and cytoplasm (18, 19). The RENT complex appears to
have multiple functions besides Cdc14 regulation including
roles in maintaining the integrity of the nucleolus (20, 21) and
sequestering Sir2 to tandem rDNA repeats (21). The NAD-de-
pendent histone deacetylase activity of Sir2 silences rDNA
chromatin and represses recombination among tandem rDNA
repeats, a deleterious process that leads to senescence of cells
(22–24).
The mechanism by which Cdc14 is released from Net1 is not
yet clear, but it is dependent in part on activation of a signaling
pathway known as the mitotic exit network (9, 11, 12). When
the dividing nucleus spans the bud neck during late mitosis,
the mitotic exit network pathway is activated, and a signal is
propagated which promotes release of Cdc14 (25, 26). The APC/
C-mediated destruction of the anaphase inhibitor Pds1 is not
only necessary for sister-chromatid separation but also for the
subsequent release of Cdc14 (27–29). However, Pds1 degrada-
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tion and Cdc14 release are not sufficient for exit from mitosis
unless the Clb5 cyclin has also been destroyed by the APC/C at
the metaphase to anaphase transition (28). Thus, multiple
controls ensure that exit from mitosis occurs only after chro-
mosome segregation and correct partitioning of the dividing
nucleus to the mother and daughter cells (25, 26, 28–30).
Previous studies have not determined whether Net1 on its
own is sufficient to inhibit Cdc14 activity. In this paper we have
characterized the direct effect of Net1 on Cdc14 activity in
vitro. We have shown that a 600-residue NH2-terminal frag-
ment of Net1 alone binds the catalytic domain of Cdc14 and
acts as a potent and specific competitive inhibitor of its activity
toward physiologic substrates. We have defined a segment of
Net1 spanning residues 1–341 which contains the Cdc14 bind-
ing site and fully inhibits phosphatase activity. We also provide
evidence that Net1 acts by occluding the active site of Cdc14.
EXPERIMENTAL PROCEDURES
Construction of Plasmids—Plasmids were constructed using stand-
ard cloning and polymerase chain reaction techniques as briefly out-
lined below. The authenticity of all plasmids was verified by DNA
sequencing. For two-hybrid analyses, the coding sequence of the CDC14
gene was cloned into the pGBDU-C1 vector (31) to create pGBDU-
CDC14, which encodes a fusion protein with the GAL4 DNA binding
domain. Using polymerase chain reaction, the NET1 coding sequence
was inserted into pGAD-C1 (31) to produce pGAD-NET1, which ex-
presses a fusion protein with the GAL4 activation domain. Restriction
fragments derived from pGAD-NET1 were used to construct a series of
six pGAD plasmids encoding fusion proteins comprised of Net1 trunca-
tion mutants containing residues 1–601, 1–341, 1–207, 92–341, 342–
1189, and 92–1189. A pGAD vector encoding a fusion protein with
Net1(1–146) was constructed using a fragment amplified by polymerase
chain reaction. The complete SWI5 coding sequence and codons 1–600
of NET1 were amplified by polymerase chain reaction and inserted into
pET21a to generate the pET-SWI5-His6 and pET-NET1(1–600)-His6
expression plasmids. A restriction fragment from pGAD-Net1(1–341)
was inserted into pET21a to give pET-NET1(1–341)-His6 expression
plasmid. All of these pET expression plasmids encode proteins bearing
NH2-terminal T7 tags.
Yeast Two-hybrid Screens and Assays—A two-hybrid screen was
performed by transforming the yeast strain PJ69–4A (31) with the
pGBDU-CDC14 plasmid expressing the Cdc14 bait protein. This strain
was then transformed with each of three S. cerevisiae Y2HL genomic
libraries (31), and about 2 3 106 colonies with each library were
screened for activation of the HIS3 and ADE2 reporter genes (see
below). After establishing that reporter activation was dependent on
the presence of both bait and target proteins, plasmids from positive
clones were isolated and sequenced. This screen identified several pos-
itive clones containing 59-coding sequences from the yeast YJL076W
(NET1) gene.
Two-hybrid assays were used to assess the ability of Net1 truncation
mutants to interact with Cdc14. After transformation of the yeast strain
PJ69–4A (31) with the pGBDU-CDC14 plasmid and a pGAD vector
encoding one of the Net1 truncation mutants (see above) cells were
plated on medium permitting detection of reporter gene activation.
Ade1 cells were identified by growth on SC medium lacking adenine,
leucine, and uracil, whereas His1 cells grew on SC medium lacking
histidine, leucine, and uracil but containing 1 mM 3-aminotriazole.
Activation of the lacZ reporter gene was assessed by performing liquid
b-galactosidase assays as described (31).
Protein Expression and Purification—Yeast GST-Cdc14 and GST-
Cdc14(1–374) were overexpressed in Escherichia coli BL21 (DE3) cells
as described (1) except that lysates were treated with polyethylenei-
mine (PEI) prior to affinity purification. Using a stock solution of 5%
(w/v) PEI at pH 8, lysates were adjusted to a final PEI concentration of
0.15% (w/v) and centrifuged at 10,000 3 g for 10 min at 4 °C. The pellet
was resuspended in 1 volume of lysis buffer containing 500 mM NaCl,
mixed and clarified by centrifugation (10,000 3 g for 10 min) prior to
purification using glutathione-Sepharose (1). The GST-HCdc14A (1–
379) and GST-HCdc14B (1–418) fusion proteins were expressed in E.
coli BL21 (DE3) cells from pET-GST vectors (1) and purified from
PEI-treated extracts as described above. The TC45 splice variant of the
human T cell phosphatase was expressed and purified using the method
of Hao et al. (32). Purified recombinant VHR and PPT1 protein phos-
phatases were provided by Drs. Zhong-Yin Zhang and S. Rossie,
respectively.
E. coli BL21 (DE3) cells transformed with expression plasmids en-
coding Net1(1–600)-His6, Net1(1–341)-His6, and Swi5-His6 were grown
at 37 °C in LB medium containing 100 mg/ml ampicillin until the A600
was about 0.7. Following the addition of 50 mM isopropyl-1-thio-b-D-
galactopyranoside, cells expressing Net1(1–600)-His6 and Swi5-His6
were grown for 14–16 h at room temperature, whereas cells producing
Net1(1–341)-His6 were induced with 400 mM isopropyl-1-thio-b-D-galac-
topyranoside and grown for 4 h at 30 °C. Swi5-His6 and Net1(1–600)-
His6 were purified directly from extracts using His-Bind resin (Nova-
gen) according to protocols from the manufacturer, whereas lysates
containing Net1(1–341)-His6 were treated with PEI as described above
before purification on His-Bind resin.
For further purification, Net1(1–600)-His6 (1–2 mg) was dialyzed
with buffer A (50 mM Tris, pH 8.0, 2 mM EDTA, 0.1% (v/v) 2-mercap-
toethanol), loaded on a Mono Q HR 5/5 column, and eluted with a 25-ml
linear gradient from 0 to 500 mM NaCl in buffer A using a fast protein
liquid chromatography system (Amersham Pharmacia Biotech). Peak
fractions were combined, dialyzed with 50 mM imidazole, pH 6.6, 1 mM
EDTA, 0.1% (v/v) 2-mercapthoethanol for phosphatase assays or with
25 mM Tris, pH 7.4, 2.6 mM KCl, 137 mM NaCl, 0.1% (v/v) 2-mercapto-
ethanol for in vitro binding assays and concentrated with Centricon-10
(Amicon) membranes. Net1(1–341)-His6 was purified further on a
Sephacryl S300 HR 1 3 80-cm column (Amersham Pharmacia Biotech)
equilibrated in 50 mM imidazole, pH 6.6, 350 mM NaCl, 1 mM EDTA,
0.1% (v/v) 2-mercapthoethanol and eluted at a flow rate of 0.5 ml/min
using the fast protein liquid chromatography system. Peak fractions
were combined and concentrated by either ultrafiltration with a Cen-
triprep-10 (Amicon) membrane or dehydration in a dialysis bag covered
with dry Sephadex G-25. Sic1-Myc-His6 was expressed as a fusion
protein with maltose-binding protein and purified as described (33).
The Cdc28 cyclin-dependent kinase was immunopurified from yeast
as a complex with either the Clb2 or Cln2 cyclin carrying epitope tags
derived from human influenza virus hemagglutinin (HA) as described
(34). Yeast with copies of either GAL1-HA-CLB2 or GAL1-HA-CLN2
genes were grown in medium containing 2% galactose to induce expres-
sion and disrupted with glass beads. The HA-Clb2zCdc28 and HA-
Cln2zCdc28 kinase complexes were immunopurified from extracts using
12CA5 monoclonal antibodies cross-linked to protein A-Sepharose
beads (34).
In Vitro Binding Assays—GST, GST-Cdc14, and GST-Cdc14 C283S
affinity matrices were prepared by adding 0.5 nmol of each protein to
200 ml of a 50% slurry of glutathione-Sepharose in binding buffer B (25
mM Tris, pH 7.4, 137 mM NaCl, 2.6 mM KCl, 0.1% (v/v) 2-mercaptoeth-
anol). Each mixture was incubated for 30 min at 4 °C in a final volume
of 1 ml buffer B. The supernatant was removed, and each of the three
affinity matrices was suspended in buffer B and split into two aliquots
of equal volume. 1 nmol of Net1 in buffer B was added to one aliquot of
each affinity matrix (final volume of 1 ml of buffer B), whereas the
second sample of affinity resin received an equal volume of buffer B
without Net1. After mixing by inversion for 30 min at 4 °C, the resin
was centrifuged and washed four times with 1 ml of buffer B containing
0.01% (v/v) Triton X-100. Washed beads were suspended in 50 ml of 2 3
SDS-PAGE loading buffer, boiled for 5 min, and an aliquot (20 ml) was
separated on a 12% SDS-polyacrylamide gel. Proteins were visualized
by staining the gel with Coomassie Blue. Densitometry was used to
estimate the relative amounts of Net1 fragment and GST-Cdc14 pro-
teins in the SDS gels assuming that the two proteins have equal
staining with Coomassie dye. Images of gels dried between translucent
membranes were obtained from a scanner (Astra 2200, Umax) used in
the transparency mode and analyzed using ImageQuant software (Mo-
lecular Dynamics).
Preparation of 32P-labeled Substrates—Swi5 and histone H1 were
phosphorylated with [g-32P]ATP using the partially purified HA-
Clb2zCdc28 complex, whereas Sic1 was phosphorylated with the HA-
Cln2zCdc28 kinase (see above). Myelin basic protein (MBP) (Life Tech-
nologies, Inc.) was phosphorylated on tyrosine using GST-lyn kinase as
described (35). Radiolabeled casein phosphorylated on Ser residues was
provided by Dr. S. Rossie. Protein substrate concentrations given herein
represent the total concentration of phosphorylated residues used in
each assay.
Phosphatase Assays—The phosphatase activity of yeast Cdc14,
HCdc14A, HCdc14B, VHR, and TC45 toward pNPP and protein sub-
strates was measured as described (1, 32) in reactions carried out at
30 °C for 5–40 min in buffer containing 50 mM imidazole, pH 6.6, 1 mM
EDTA, 1 mM dithiothreitol, and 0.5 mg/ml bovine serum albumin.
Assays with radiolabeled Sic1, Swi5, histone H1, and Tyr(P)-MBP sub-
strates were performed in a total volume of 30 ml; 50-ml reactions were
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employed for pNPP and casein. The final assay buffer for yeast PPT1
contained 56 mM Tris, 36 mM imidazole, pH 7.2, 1.8 mM EDTA, 1.2 mM
EGTA, 0.1% 2-mercaptoethanol, 0.5 mg/ml bovine serum albumin, and
6 mM phosphocasein.
Limited Proteolysis of Net1(1–600)-His6—Digestion with Staphylo-
coccus aureus V8 protease (0.15 mg) was performed for 60 min at room
temperature with 75.5 mg Net1(1–600) in 0.5 ml of buffer containing 40
mM ammonium bicarbonate, pH 7.8, 4 mM Tris, 22 mM NaCl, 0.4 mM
KCl, 3% (v/v) glycerol, and 0.02% (v/v) 2-mercaptoethanol. Cleavage
with 1.5 mg of endoproteinase Arg-C (stored at 220 °C in water) was
carried out at 30 °C as described above for staphylococcal V8 protease
except that the digestion buffer contained 80 mM ammonium bicarbon-
ate at pH 8. Aliquots (50 ml) of each digest were precipitated with
trichloroacetic acid as described previously (32) and analyzed on 12%
SDS-polyacrylamide gels. The remainder of each reaction (equivalent to
1 nmol of the Net1(1–600) fragment) was stopped by adding soybean
trypsin inhibitor to a final concentration of 1 mg/ml and used for in vitro
binding assays with affinity matrices containing 0.25 nmol of GST-
Cdc14 or GST (see above). For amino acid sequencing, proteolytic frag-
ments were resolved by SDS-PAGE and transferred to polyvinylidene
difluoride membranes as described (36). Protein bands on the mem-
brane were stained with Coomassie Blue, excised, and analyzed by
automated gas phase sequencing.
Determination of the Mode of Inhibition and Ki—Because of its high
affinity for Cdc14, the Henderson method (37) for tight binding inhib-
itors was used for the analysis of Net1 inhibition. For these experi-
ments, the activity of GST-Cdc14 (5 nM) was measured at six different
substrate concentrations ranging from 0.27 to 17 mM Tyr(P)-MBP. For
each concentration of substrate, six assays were performed with
Net1(1–600) concentrations between 0 and 100 nM. For each substrate
concentration, the value It/(1 2 vi/v0) was plotted on the y axis versus
v0/vi on the x axis, where It is the total Net1(1–600) concentration, and
vi and v0 are the velocities with and without inhibitor, respectively. This
plot generates a series of lines for each concentration of substrate which
were fit by unweighted linear regression using a fixed intercept value of
5 nM, which was the total enzyme concentration (37). The Ki and
mechanism of inhibition were determined from a replot of the slopes of
these lines versus substrate concentration.
RESULTS
Net1 (1–600)-His6 Alone Binds Cdc14 Directly—In addition
to a genetic screen described by Shou et al. (18), we and others
(19) also identified Net1 in a yeast two-hybrid screen for reg-
ulators or substrates of Cdc14 (Table I). Along with the immu-
nolocalization and genetic studies (18–20), these two-hybrid
results support the notion that Net1 and Cdc14 interact in vivo,
but they fail to establish whether this interaction is direct or
mediated by other proteins. To determine whether there is a
direct interaction between Net1 and Cdc14 in vitro, we used
binding assays employing recombinant GST-Cdc14 (1) and
Net1(1–600)-His6. This NH2-terminal fragment of Net1 was
used to preclude problems associated with the bacterial expres-
sion of the 1,189-residue full-length protein. Sequence analysis
of Net1 clones obtained in our two-hybrid screens indicated
that the NH2-terminal half of Net1 (residues 1–641) interacted
with Cdc14. A two-hybrid assay confirmed that a fragment of
Net1 containing residues 1–601 could interact with Cdc14 (Ta-
ble I, third row).
Purified GST-Cdc14 or GST alone was immobilized on glu-
tathione-Sepharose beads and incubated with a 4-fold molar
excess of Net1(1–600). SDS-PAGE analysis (Fig. 1) revealed
that Net1(1–600) was retained by the GST-Cdc14 affinity sup-
port but not by immobilized GST alone. The molar ratio of
GST-Cdc14 to Net1(1–600) on the affinity matrix (Fig. 1, lane
4) was estimated to be 1:1 using densitometric analysis of the
SDS-gel. This experiment corroborates results from two-hybrid
analyses and demonstrates that in vitro Net1(1–600) binds
GST-Cdc14 with high affinity and in a manner that is not
dependent on other proteins.
Net1 Is a Potent Inhibitor of Cdc14 Activity—Evidence that
Net1 negatively regulates Cdc14 activity includes the ability of
a recessive net1 mutant to bypass the requirement for Tem1
and Cdc15 in promoting exit from mitosis (18), an elevation of
Cdc14 activity in net1 mutants (18), the ability of Net1 over-
production to suppress cell cycle defects induced by Cdc14
overexpression (19, 20), and the inactivation of GST-Cdc14 by
immunopurified Net1 (18). To corroborate these findings and to
determine whether Net1 alone directly inhibits Cdc14 activity,
we measured the effect of purified Net1(1–600) on GST-Cdc14
activity in vitro.
The transcription factor Swi5 and the Cdc28 inhibitor Sic1,
which are physiologic Cdc14 substrates (8), were employed to
evaluate the efficacy of Net1 as an inhibitor. Both substrates
TABLE I
Two-hybrid interaction of Net1 or Net1 mutants with Cdc14
Yeast two-hybrid assays (31) were used to assess the ability of Net1
or Net1 truncation mutants to interact with Cdc14. Yeast (PJ69–4A)
expressing a Cdc14 fusion protein with the GAL4 DNA binding domain
(pGBDU-CDC14) were transformed with pGAD plasmids encoding
Net1 or Net1 truncation mutants fused with the GAL4 DNA activation
domain. Protein-protein interactions were detected by selection for















pGAD-C3 alone 2 2 3.2 1.0/2
Net1 1 2 4.5 1.4/1
Net1(1–601) 1 1 12.4 3.8/1
Net1(1–341) 1 1 8.0 2.5/1
Net1(342–1189) 2 2 3.1 1.0/2
Net1(1–207) 1 2 3.5 1.1/2
Net1(1–146) 2 2 2.1 0.6/2
Net1(92–1189) 1 1 4.5 1.4/1
Net1(92–341) 2 2 3.1 1.0/2
a Transformants were screened for activation of the HIS3 gene on
SC-His-Leu-uracil medium containing 1 mM 3-aminotriazole.
b b-Galactosidase activities are the mean of values obtained in trip-
licate. These data are representative of the results obtained from four
different experiments.
c Values differing from control by more than 0.5 Miller unit were
statistically significant indicating activation of the lacZ gene as shown
with a plus (1) sign.
FIG. 1. Net1(1–600) binds Cdc14 in vitro. GST, GST-Cdc14, and
GST-Cdc14 C283S affinity matrices were prepared by binding 0.25
nmol of each protein to glutathione-Sepharose beads. Purified Net1(1–
600)-His6 (1 nmol) was incubated for 30 min at 4 °C with each affinity
matrix in 1 ml of buffer B. After washing with buffer B containing 0.01%
(v/v) Triton X-100, an aliquot (20%) of each Net1(1–600)-His6-treated
matrix (lanes 2, 4, and 6) and the untreated controls (lanes 1, 3, and 5)
were mixed with sample buffer and separated on 12% SDS-polyacryl-
amide gels. An aliquot (7 mg) of purified Net1(1–600)-His6 used in these
studies was also subjected to SDS-PAGE (lane 7). Protein was visual-
ized by staining with Coomassie Blue. The positions of molecular mass
markers are shown on the left, and the locations of GST-Cdc14 and
Net1(1–600)-His6 are indicated on the right. These results are repre-
sentative of those obtained in multiple experiments.
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are phosphorylated in vivo by the Cdc28 protein kinase in a
complex with either mitotic or G1 cyclins, respectively (33, 38).
For use in inhibition assays, recombinant Sic1 and Swi5 were
phosphorylated in vitro using immunopurified complexes of
Cln2zCdc28 and Clb2zCdc28 kinases, respectively. Net1(1–600)
potently inhibited the dephosphorylation of both Sic1 and Swi5
by GST-Cdc14 with IC50 values of 2 and 1 nM, respectively (Fig.
2A). Net1(1–600) also inhibited activity toward three artificial
substrates, pNPP, histone H1 phosphorylated on Ser/Thr res-
idues (data not shown) and as shown below, Tyr(P)-MBP. We
observed a dependence of IC50 values on the total GST-Cdc14
concentration over a range from 1 to 34 nM, indicating that
Net1 binds in a stoichiometric manner, which is consistent
with a dissociation constant of 10 nM or less.
The Noncatalytic Domain of Cdc14 Is Not Required for Net1
Binding and Inhibition—The Asn/Ser-rich COOH-terminal do-
main (residues 375–551) of yeast Cdc14 is not required for its
activity or its role in promoting cell cycle progression (1). To
assess the role of this noncatalytic domain in binding Net1, in
vitro binding and inhibition studies were performed with GST-
Cdc14(1–374), a fully active mutant of Cdc14 containing the
catalytic domain. The amount of Net1(1–600) bound by immo-
bilized GST-Cdc14(1–374) was comparable to that observed
with equivalent quantities of the full-length GST-Cdc14 affin-
ity matrix (data not shown). Using Tyr(P)-MBP as an artificial
substrate (1), Net1(1–600) inhibited both GST-Cdc14 and GST-
Cdc14(1–374). The IC50 value measured with the catalytic do-
main, Cdc14(1–374), was about 1.5-fold greater than that for
the full-length enzyme (data not shown). Similar results were
obtained using pNPP as substrate. These data show that Net1
binds to a site residing within the catalytic domain and indicate
that the Asn/Ser-rich COOH-terminal domain has little influ-
ence on the affinity of Cdc14 for Net1.
Effect of Ionic Strength on Net1 Inhibition—Because of the
substantial reduction in GST-Cdc14 activity in the presence of
more than 100 mM monovalent salt (1), the inhibition studies
described above were performed in low salt buffers having
nonphysiologic ionic strength. Therefore, the sensitivity of
GST-Cdc14 to Net1(1–600) was also measured in buffer having
an ionic strength comparable to that in the cell. In the presence
of 120 mM KCl, the IC50 value for Net1(1–600) increased from
5.6 to 74 nM (data not shown). The 10-fold reduction in affinity
of Net1 for Cdc14 was not accompanied by changes in the shape
of the inhibition curve.
Net1 Is a Specific Inhibitor of Yeast Cdc14 Activity—To as-
sess its specificity for Cdc14, we examined the ability of
Net1(1–600) to inhibit other enzymes of the PTP family. The
activity of the dual-specific phosphatase VHR (39) and the
TC45 variant of the tyrosine-specific T cell phosphatase (32)
were not affected by the addition of Net1(1–600) at concentra-
tions 300-fold greater than those giving half-maximal inhibi-
tion of GST-Cdc14 (data not shown). Likewise, up to 1 mM
Net1(1–600) had no effect on the activity of yeast PPT1, a
PP5-like enzyme of the Ser/Thr phosphatase family (40).
The two human homologs of yeast Cdc14 were also not in-
hibited by Net1 (data not shown). At concentrations up to 0.3
mM, Net1(1–600) had no effect on GST-HCdc14A (1–379) and
GST-HCdc14B (1–418)2, fusion proteins containing the cata-
lytic domains from each of the human Cdc14 phosphatases (2).
At 3 mM Net1(1–600), HCdc14A and HCdc14B were stimulated
1.5- and 2.5-fold, respectively. Under conditions identical to
those employed with yeast Cdc14, there was no detectable
binding of Net1(1–600) to affinity matrices containing the
HCdc14A and B catalytic domains (data not shown). Thus,
Net1 not only fails to inhibit, but is also incapable of binding
the human enzymes. These data indicate that Net1 exhibits a
high degree of specificity for yeast Cdc14.
Net1 Is a Competitive Inhibitor of Cdc14—To determine the
type of inhibition and Ki value, the Henderson method (37) for
analyzing tight binding inhibitors was used with Net1(1–600).
A representative experiment using Tyr(P)-MBP as substrate is
shown in Fig. 2, B and C. The linear increase in slope with
increasing substrate concentration shown in the slope replot of
Fig. 2C indicates that Net1(1–600) is a competitive inhibitor of
Cdc14. The intercept of the slope replot yields a Ki value of 3
nM. A similar Ki was obtained using pNPP as substrate (data
not shown).
To evaluate the possibility that Net1 binds at the active site,
we examined the effect of sodium tungstate on the interaction
with Cdc14. Tungstate, a competitive inhibitor of PTPs includ-
ing yeast Cdc14 (1), binds within the active site of these en-
zymes. Pretreatment with sodium tungstate reduced in a con-
centration-dependent manner the amount of Net1(1–600) that
was bound to a GST-Cdc14 affinity matrix (Fig. 3, A and B).
These results show that Net1 and tungstate binding are mu-
tually exclusive and suggest that access to the phosphatase
active site is necessary for the interaction with Net1. The
reduced affinity of Net1(1–600) for the Cdc14 C283S active site
mutant is consistent with this conclusion. Under identical con-
ditions, the amount of Net1(1–600) bound to an affinity matrix
2 L. Has, T. Despande, Y. Liu, G. S. Taylor, C. Baskerville, and
H. Charbonneau, manuscript in preparation.
FIG. 2. Net1(1–600) is a potent competitive inhibitor of Cdc14
activity. Panel A, the phosphatase activity of 4 nM and 1 nM GST-
Cdc14 with 3 mM phospho-Sic1 (E) and 2 mM phospho-Swi5 (l ), respec-
tively, was measured in the presence of the indicated concentrations of
recombinant Net1(1–600)-His6. Phosphatase activity is plotted as the
percent of the control value measured in the absence of Net1(1–600)-
His6. Each point is the mean of three to five determinations. Inhibition
curves were obtained using nonlinear regression analysis to fit the data
to an equation for a rectangular hyperbola. Protein was estimated by
the method of Bradford (49) using bovine serum albumin as standard.
Panel B, the mode of inhibition for Net1(1–600)-His6 was determined
using the methods for tight binding inhibitors described by Henderson
(37). GST-Cdc14 activity was determined in the presence of varying
Net1(1–600)-His6 concentrations at the following Tyr(P)-MBP sub-
strate concentrations: 0.27 mM (), 0.54 mM (), 2.2 mM (M), 4.3 mM (f),
8.7 mM (E), and 17 mM (l ). For each substrate concentration, It/(1 2
vi/v0) versus v0/vi was plotted where It is the total Net1(1–600)-His6
concentration, and vi and v0 are the velocities measured with and
without inhibitor, respectively. Each data point is the mean of three
determinations. Panel C, the Ki was derived from a replot of the slopes
(l ) (6 S.E.) obtained for each line in panel B versus Tyr(P)-MBP
concentration. The y intercept of this plot yields the Ki value.
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comprised of the GST-Cdc14 C283S mutant was 54% of that
bound to a matrix formed with the wild type enzyme (compare
lanes 4 and 6 of Fig. 1).
Identification of an NH2-terminal Net1 Fragment That
Binds and Inhibits Cdc14—To delineate further the Cdc14
binding region of Net1 a series of truncation mutants lacking
both NH2- and COOH-terminal sequences was analyzed us-
ing yeast two-hybrid assays. The Net1(1–341) truncation mu-
tant interacted with Cdc14 as shown by activation of all three
reporter genes in the two-hybrid system (Table I, fourth row).
To assess its functional properties and confirm the two-
hybrid results, Net1(1–341)-His6 was expressed in E. coli. An
in vitro binding experiment performed in a manner compa-
rable to that used for Net1(1–600) showed that purified
Net1(1–341) was bound to the GST-Cdc14 affinity matrix
(Fig. 4A, lane 2). A relatively small but detectable amount of
Net1(1–341) was retained by GST alone (Fig. 4A, lane 4). The
addition of 300 mM NaCl eliminated the association of
Net1(1–341) with GST without a significant reduction in
binding to GST-Cdc14 (data not shown). This effect may be
explained by the ability of salt to suppress the aggregation of
Net1(1–341) and thereby prevent the retention of small
amounts of insoluble protein on the affinity matrices. Using
Tyr(P)-MBP as substrate, the IC50 for Net1(1–341) was 9.7
nM, about 3-fold higher than that measured for Net1(1–600)
under identical conditions (Fig. 4B). These results demon-
strate that Net1(1–341) retains the ability to bind and fully
inhibit Cdc14 albeit with a modest reduction in affinity com-
pared with Net1(1–600).
Among 11 truncation mutants examined, no NH2-terminal
fragments shorter than Net1(1–341) were shown conclusively
to bind Cdc14. In two-hybrid assays, Net1(1–146) was unable
to associate with Cdc14, and the results with a segment
comprised of residues 1–207 were interpreted as being neg-
ative because only one of the three reporter genes was acti-
vated (Table I, sixth and seventh rows). Consistent with
these results, a 27-kDa product obtained from limited cleav-
age by the Arg-C protease failed to bind a GST-Cdc14 affinity
matrix despite containing as many as the first 242 residues
from the NH2 terminus of Net1 (see below). In addition, a
preparation of 35S-labeled Net1(1–242) which was produced
using the reticulocyte in vitro translation system also failed
to bind a GST-Cdc14 affinity matrix. The failure to express
His-tagged Net1(1–276) and Net1(1–207) in E. coli precluded
the analysis of these fragments in binding and inhibition
assays.
Net1 truncation mutants with 112 or more residues deleted
from the NH2 terminus failed to interact with Cdc14 in two-
hybrid assays (data not shown). The Net1(92–1189) mutant
interacted with Cdc14 (Table I, eighth row), whereas deletion of
the same 91-residue segment from Net1(1–341) abrogated the
interaction (Table I, ninth row). These results indicate that the
FIG. 3. Sodium tungstate blocks the binding of Net1(1–600) to
Cdc14. Panel A, an in vitro binding assay was performed as described
for Fig. 1 except that the GST-Cdc14 affinity matrices were incubated
with 0.1, 1.0, and 10 mM sodium tungstate for 20 min prior to the
addition of 1 nmol of Net1(1–600)-His6 (lanes 3–5). The incubation with
Net1(1–600)-His6 and subsequent washing steps were done in the pres-
ence of the indicated concentration of sodium tungstate. After washing,
the affinity matrices were collected and separated on a 12% SDS-
polyacrylamide gel. Lane 1 shows the GST-Cdc14 affinity matrix alone,
and lane 2 shows the amount of Net1(1–600)-His6 bound in the absence
of sodium tungstate. Protein was visualized by staining with Coomassie
Blue. The positions of molecular mass markers are shown on the left,
and the locations of GST-Cdc14 and Net1(1–600)-His6 are indicated on
the right. Panel B, the relative amount of Net1(1–600)-His6 bound to
the GST-Cdc14 affinity matrix in the presence of the indicated concen-
trations of sodium tungstate. The relative amount of bound Net1(1–
600)-His6 was estimated by densitometry of the SDS-gel in panel A as
outlined under “Experimental Procedures.”
FIG. 4. Net1(1–341) binds and inhibits Cdc14 in vitro. Panel A,
purified Net1(1–341)-His6 (1 nmol) was incubated for 30 min at 4 °C
with GST and GST-Cdc14 affinity matrices containing 0.25 nmol of
each protein. Affinity matrices and Net1(1–341) were mixed in 1 ml of
buffer B. After washing with buffer B containing 0.01% (v/v) Triton
X-100, the affinity matrices, both those mixed with Net1(1–341)-His6
(lanes 2 and 4) and untreated controls (lanes 1 and 3), were treated with
sample buffer and resolved on 12% SDS-polyacrylamide gels that were
stained with Coomassie Blue. The positions of molecular mass markers
are shown on the left, and the positions of GST-Cdc14 and Net1(1–341)-
His6 are indicated on the right. Panel B, the relative phosphatase
activity of 2.5 nM GST-Cdc14 with 3.2 mM Tyr(P)-MBP as substrate was
measured in the presence of the indicated concentrations of recombi-
nant Net1(1–600)-His6 (l ) and Net1(1–341)-His6 (E). Phosphatase ac-
tivity is given as the percent of the control value measured in the
absence of Net1 fragment, and each data point is the mean of at least
three determinations.
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first 91 residues at the NH2 terminus of Net1 may not be
necessary for Cdc14 binding, but they may influence the sta-
bility or folding of Net1, particularly in the context of the
smaller Net1(1–341) fragment.
Limited Proteolytic Cleavage of Net1(1–600)—To examine
its domain and structural organization, recombinant Net1(1–
600) was subjected to limited proteolysis using trypsin, chy-
motrypsin, subtilisin, endoproteinase Arg-C, and S. aureus
V8 proteases. Utilizing low protease to substrate ratios (1:
500–1:2,000) typically employed in limited proteolysis stud-
ies, Net1(1–600) was degraded rapidly by trypsin, chymo-
trypsin, and subtilisin, providing no evidence for canonical
protease-resistant domains (data not shown). However, di-
gestion with Arg-C and V8 proteases released in modest yield
fragments exhibiting partial resistance to proteolysis (Fig. 5,
A and B). These products were tested for their ability to bind
GST-Cdc14 using in vitro binding assays as described above.
A major 42-kDa fragment and multiple minor products from
the V8 protease digest were bound by the GST-Cdc14 affinity
matrix (Fig. 5A) but not by GST alone (data not shown). The
amino acid sequence of the 42-kDa fragment matched that of
the NH2 terminus of recombinant Net1(1–600) (Fig. 5C). The
COOH-terminal residue of this fragment is unknown, but its
size (estimated from SDS-PAGE mobility) suggests that it
could extend up to Glu-369.
Cleavage with endoproteinase Arg-C yielded three major
products, a 27-kDa fragment and two polypeptides migrating
as a doublet around 57-kDa (Fig. 5B). The NH2 termini of the
27-kDa fragment and the major component of the doublet were
determined by sequence analysis, but the location of their
COOH termini was based on size estimates derived from SDS-
gel mobilities. The 27-kDa fragment is derived from the NH2
terminus and could extend from residue 1 to either Arg-216 or
Arg-241 (Fig. 5C). The 57-kDa product was generated by cleav-
age after Arg-184, and its large size suggests that it contains
residues 185–600 of Net1 (Fig. 5C). Because neither product
binds GST-Cdc14 (Fig. 5B), it appears that Arg-C cleavage
disrupts a contiguous sequence surrounding Arg-184 which is
necessary for an interaction with Cdc14 (Fig. 5C). These stud-
ies are fully consistent with results from truncation mutagen-
esis showing that residues 1–341 encompass a Cdc14 binding
region.
DISCUSSION
Current models (15–18) posit that Net1 retains inactive
Cdc14 in the nucleolus during interphase and early mitosis
until the transient release of the active phosphatase at late
anaphase triggers exit from mitosis. The intrinsic biochemi-
cal properties of Net1(1–600) which we have observed in vitro
fully support this model. Nanomolar concentrations of
Net1(1–600) alone fully inhibited the activity of Cdc14
through a direct interaction that was not dependent on other
proteins. The effect of Net1(1–600) was specific to Cdc14 and
observed with all substrates examined including the physio-
FIG. 5. Analysis of proteolytic fragments of Net1(1–600). Panel A, Net1(1–600)-His6 was digested with staphylococcal V8 protease for 60
min at room temperature using a protease:Net1weight ratio of 1:500. Aliquots of an untreated control (lane 1) and the digested sample (lane 2) were
precipitated with trichloroacetic acid and separated on a 12% SDS-polyacrylamide gel. The remaining sample was treated with soybean trypsin
inhibitor and analyzed for its ability to bind to a GST-Cdc14 affinity matrix (see Fig. 1). Lane 3, washed GST-Cdc14 matrix without added V8
digest; lane 4, washed GST-Cdc14 matrix mixed with the V8 digest; lane 5, digested material not bound by the affinity matrix. Panel B,
Net1(1–600)-His6 was digested with Arg-C protease for 60 min at 30 °C using a protease:Net1 weight ratio of 1:50. Samples of untreated (lane 1)
and digested (lane 2) Net1(1–600)-His6 were analyzed as above for panel A. An in vitro Cdc14 binding assay was performed on an aliquot of the
Arg-C digest as in panel A. Lane 3, washed GST-Cdc14 matrix without added Arg-C digest; lane 4, washed GST-Cdc14 matrix mixed with the Arg-C
digest; lane 5, digested material not bound by the affinity matrix. Protein was visualized by staining with Coomassie Blue. In panels A and B, the
positions of GST-Cdc14, Net1(1–600)-His6, and proteolytic fragments are indicated on the right. Panel C, schematic diagram illustrating the
structural organization of full-length Net1 (upper bar) and the location of the major fragments (black lines) derived from limited proteolysis.
The NH2 termini of fragments were mapped by amino acid sequence analysis, whereas the dashed lines indicate that the locations of COOH termini
were deduced from size as estimated by SDS-PAGE and were not determined directly. The shaded box within the upper bar delineates the location
of sequences containing the Cdc14 binding site, and the black box denotes the position of the Sir2 binding region as determined by Cuperus et al.
(41). The cross-hatched bar below indicates the location of Net1 sequences displaying a high degree of sequence similarity to Tof2.
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logic targets, Swi5 and Sic1. Importantly, Net1(1–600) re-
tained its ability to act as a high affinity inhibitor (IC50 5 70
nM) when buffers approximating physiologic ionic strength
and pH were employed. These findings demonstrate that
Net1 alone has the capacity to regulate all cellular functions
requiring Cdc14 by sequestering the phosphatase from the
nucleoplasm to the nucleolus and fully inhibiting its activity.
Our results also suggest that post-translational modifica-
tions of the type commonly observed in eukaryotes are un-
likely to be required for inhibition because Net1(1–600) was
produced in bacteria. However, post-translational modifica-
tion or the binding of other protein ligands could influence
the affinity of Net1 for Cdc14 and may mediate the release of
Cdc14 at late anaphase as suggested previously (18).
Results from in vitro binding, inhibition assays, and limited
proteolytic cleavage demonstrate that residues 1–341 of Net1
are sufficient for both binding and inhibiting Cdc14 (Fig. 5C).
Two-hybrid assays suggest that the first 91 residues of Net1
are not essential for binding, but the possibility that this seg-
ment is needed for inhibition has not been excluded. Net1 also
sequesters Sir2 within the nucleolus where it is involved in
rDNA silencing. Cuperus et al. (41) have shown that residues
566–801 of Net1 interact with an NH2-terminal fragment of
Sir2 (Fig. 5C). Their results together with our data establish
that Sir2 and Cdc14 bind to distinct, non-overlapping sites
within the linear sequence of Net1 and show that neither
protein is required for binding of the other (Fig. 5C). Additional
structure-function analyses of Net1 will be required to define
the minimal sequence(s) required for binding and inhibiting
Cdc14.
Several findings suggest that Net1 inhibits by occluding
the active site of Cdc14. Net1 acts as a competitive inhibitor
of Cdc14, indicating that inhibitor and substrate binding are
mutually exclusive. The Net1 binding site has been mapped
to a position within the conserved domain of Cdc14 (residues
1–374) which encompasses the entire active site region (res-
idues 279–291). The structures (4, 42–45) of several different
PTPs reveal that tungstate, a general PTP inhibitor that
mimics the transition state, is bound within the active site in
a manner similar to the phosphate of substrates. Sodium
tungstate prevents Net1 binding in a concentration-depend-
ent manner (Fig. 3), suggesting that contacts within the
Cdc14 active site are required for binding. The significant
reduction in Net1 affinity which occurs upon replacement of
the Cdc14 active site cysteine also supports the idea that
binding involves the catalytic site. Several studies indicate
that replacement of the active site Cys can induce local
changes in the conformation and properties of PTP catalytic
sites (46, 47). For example, a Yersinia PTP mutant, in which
the analogous Cys is replaced by Ser, exhibits a 10-fold re-
duction in affinity for tungstate (47). Although we propose an
interaction within the catalytic cleft of Cdc14, it is likely that
contacts with flanking surfaces are also involved. Interac-
tions with adjacent surfaces could account for the selectivity
of Net1 for the yeast enzyme over human Cdc14 and other
PTPs despite the high degree of sequence similarity in their
catalytic sites. These data favor a model in which Net1 binds
at the active site, but we cannot rule out the possibility that
it binds to a distinct inhibitory site and competes indirectly
through long range interactions that result in conformational
changes at the substrate binding site. Additional studies will
be required to delineate further the precise location of the
Net1 binding site.
Residues 1–220 of Net1 exhibit 30% sequence identity to
residues 1–233 of another yeast protein Tof2 (Fig. 5C). Other
than its ability to interact with DNA topoisomerase I (48), little
is known about the function of Tof2. Although the Tof2-like
segment is contained within the Cdc14 binding region defined
by these studies (Fig. 5C), it is not yet clear whether these
sequences are involved directly in binding and/or inhibition.
The lack of binding observed with the 27-kDa cleavage product
of Net1, which spans most if not all of these conserved se-
quences, suggests the Tof2-like region may not have a direct
role in regulating Cdc14.
The Caenorhabditis elegans, Drosophila, and human ge-
nomes and the sequence data bases contain no open reading
frames exhibiting significant sequence similarity to Net1. The
lack of an extant Net1 homolog in metazoans is surprising
because Cdc14 phosphatase genes are found in the C. elegans,
Drosophila, zebrafish, chicken, mouse, and human genomes.
This observation coupled with the insensitivity of human
Cdc14 to Net1 suggests that the regulation of metazoan and
budding yeast Cdc14 differ. In contrast to fungi, the nuclear
membrane and nucleolus of metazoans break down during
mitosis. As a result of its disassembly, higher eukaryotes may
not employ the nucleolus as a site to regulate exit from mitosis.
It will be important to determine how Cdc14 activity and its
potential function in mitotic exit are controlled in metazoans.
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